Martin Filipits

15PUBLICATIONS
129CO-AUTHORS
Deep learningMedical infection agents (incl. prions)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jun 09, 2025
Federated Deep Learning Enables Cancer Subtyping by Proteomics.

Zhaoxiang Cai, Emma L Boys, Zainab Noor

|Apr 26, 2025
The Mesothelioma Systemic Inflammation Score Is Independently Associated with Overall Survival and Predicts Benefit of Multimodality Treatment in Pleural Mesothelioma.

Berta Mosleh, Katharina Sinn, Anna Cho

|Apr 10, 2025
BRCA1/2 and Other Predisposition Genes in High-Risk Hormone Receptor+/Human Epidermal Growth Factor Receptor 2- Breast Cancer Treated With Endocrine Therapy With or Without Palbociclib: A Secondary PENELOPE-B Study Analysis.

Eric Hahnen, Jan Hauke, Karen Gelmon

|Jan 17, 2025
Neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in women with early HER2-positive breast cancer: the randomized phase 2 ABCSG-52/ATHENE trial.

Gabriel Rinnerthaler, Daniel Egle, Rupert Bartsch

|Jul 14, 2023
Epidermal Growth Factor Receptor T790M Mutation Testing in Non-Small Cell Lung Cancer: An International Collaborative Study to Assess Molecular EGFR T790M Testing in Liquid Biopsy.

Martin Filipits, Verena Kainz, Viktor Sebek

|Aug 03, 2022
Estrogen Receptor Alpha Gene Amplification Is an Independent Predictor of Long-Term Outcome in Postmenopausal Patients with Endocrine-Responsive Early Breast Cancer.

Christian F Singer, Frederik Holst, Stefan Steurer

Pageof 3

Frequent Collaborators

8 joint publications

Michael Gnant

4 joint publications

Marija Balic

3 joint publications

Zsuzsanna Bago-Horvath

2 joint publications

Daniel Egle